Onera Health kondigt de lancering aan van Onera Polysomnography-as-a-Service in geselecteerde Europese markten tijdens het International Congress 2022 van de European Respiratory Society (ERS).

EINDHOVEN, Nederland–(BUSINESS WIRE)– Onera Health, een leider in het transformeren van slaapgeneeskunde en monitoring op afstand, heeft vandaag de officiële lancering aangekondigd van zijn baanbrekende oplossing voor de diagnose van slaapstoornissen in Europa. De service is gebaseerd op het CE-gemarkeerde en door de FDA goedgekeurde Onera Sleep Test System en het Onera Digital Health Platform. Het stelt slaapprofessionals in staat om slaaponderzoeken uit te voeren bij de patiënt thuis, terwijl de kwaliteit van klinische kwaliteit behouden blijft, net als bij in-lab diagnostiek.

Ruben de Francisco, Chief Executive Officer bij Onera Health en een van de oprichters, legt uit: “Gedurende vele jaren was uitgebreide slaapdiagnostiek vooral mogelijk in klinische laboratoria die aanzienlijke middelen nodig hadden, wat resulteerde in lange wachttijden en vaak een slechte patiëntervaring. Onze innovatieve oplossing maakt grootschalig gebruik van polysomnografie thuis mogelijk. Dit zal niet alleen het comfort van de patiënt tijdens een slaaponderzoek aanzienlijk verhogen, het zal ook de toegang verbeteren en de diagnostische reizen van patiënten met slaapstoornissen verkorten.”

Onera Launches Innovative Sleep Diagnostics Solution in Europe

Onera Health announces the launch of Onera Polysomnography-as-a-Service in selected European markets at the International Congress 2022 of the European Respiratory Society (ERS).

EINDHOVEN, The Netherlands–(BUSINESS WIRE)– Onera Health, a leader in transforming sleep medicine and remote monitoring, announced today the official launch of its ground-breaking solution to diagnose sleep disorders in Europe. The service is based on the companies’ CE-marked and FDA-cleared Onera Sleep Test System and the Onera Digital Health Platform. It allows sleep professionals to conduct sleep studies at the comfort of the patients’ home while maintaining clinical-grade quality as with in-lab diagnostics.

Ruben de Francisco, Chief Executive Officer at Onera Health and one of the founders, explains: “For many years, comprehensive sleep diagnostics was mainly possible in in-patient laboratories that required significant resources, resulting in long waiting times and often poor patient experience. Our innovative solution enables large scale utilization of at-home polysomnography. This will not only increase patient comfort during a sleep study significantly, it will also improve access and shorten the diagnostic journeys of patients suffering from sleep disorders.”

“Sleep medicine struggled to keep up with the increasing prevalence of sleeping disorders for too long. Onera’s Polysomnography-as-a-Service solution allows to end delays in diagnosis, while at the same time ensuring a high-level of signal quality unseen in at-home sleep testing. This is especially important for patients with advanced or complicated sleep disorders”, adds Hartmut Schneider, MD, PhD, Chief Medical Officer and Onera Co-Founder.

Onera’s Polysomnography-as-a-Service solution will be offered in The Netherlands and Germany from 2022 onwards, with new countries in Europe being added over the next months.

The company will present new data of ongoing clinical validation studies around the Onera STS (Sleep Test System) at the 2022 ERS International Congress and exhibit its ground-breaking solution at booth #J02A, at the Fira Gran Via Convention Center Barcelona. The ERS International Congress is one of the largest medical conferences, bringing together a global audience of clinicians, scientists and researchers in the field of respiratory and sleep medicine.

Details of Onera’s abstract and poster presentation are as follows:

Title Overnight oxygen saturation is higher at the forehead compared to fingertip measurements

Date Monday, September 5, 2022, at 8:30-9:30 am CET

Poster Board Number PA2088

Authors Schneider H., Mukasa S., Mueller S., Varavinova A., Fronek F., Raschellà F, Ermers P., Vliexs M., De Francisco R.

About Onera

Onera Health is a leader in transforming diagnostics and monitoring. Their breakthrough products and technologies are poised to help millions of people struggling with health ailments and chronic conditions in a variety of medical fields, including sleep, neuro, cardiac and respiratory care, ultimately improving the health and quality of life for patients around the world. The company’s innovative solutions provide comprehensive physiological and health-related data to physicians in a variety of clinical and non-clinical environments to optimize patient care and reduce healthcare costs. Onera has offices in the Netherlands and the US. For more information, go to www.onerahealth.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20220903005001/en/

Contacts

Soukaina Adnane-Murphy

+31-(0)40 3082177

media@onerahealth.com